<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1535" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1535/" /><meta name="ncbi_pagename" content="Megalencephalic Leukoencephalopathy with Subcortical Cysts - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Megalencephalic Leukoencephalopathy with Subcortical Cysts - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Megalencephalic Leukoencephalopathy with Subcortical Cysts" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/03/29" /><meta name="citation_author" content="Marjo S van der Knaap" /><meta name="citation_author" content="Truus EM Abbink" /><meta name="citation_author" content="Rogier Min" /><meta name="citation_pmid" content="20301707" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1535/" /><meta name="citation_keywords" content="Van der Knaap Disease" /><meta name="citation_keywords" content="Van der Knaap Disease" /><meta name="citation_keywords" content="Hepatocyte cell adhesion molecule" /><meta name="citation_keywords" content="Membrane protein MLC1" /><meta name="citation_keywords" content="HEPACAM" /><meta name="citation_keywords" content="MLC1" /><meta name="citation_keywords" content="Megalencephalic Leukoencephalopathy with Subcortical Cysts" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Megalencephalic Leukoencephalopathy with Subcortical Cysts" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Marjo S van der Knaap" /><meta name="DC.Contributor" content="Truus EM Abbink" /><meta name="DC.Contributor" content="Rogier Min" /><meta name="DC.Date" content="2018/03/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1535/" /><meta name="description" content="The classic phenotype of megalencephalic leukoencephalopathy with subcortical cysts (MLC) is characterized by early-onset macrocephaly, often in combination with mild gross motor developmental delay and seizures; gradual onset of ataxia, spasticity, and sometimes extrapyramidal findings; and usually late onset of mild mental deterioration. Macrocephaly, observed in virtually all individuals, may be present at birth but more frequently develops during the first year of life. The degree of macrocephaly is variable and can be as great as 4 to 6 SD above the mean in some individuals. After the first year of life, head growth rate normalizes and growth follows a line parallel to and usually several centimeters above the 98th centile. Initial mental and motor development is normal in most individuals. Walking is often unstable, followed by ataxia of the trunk and extremities, then minor signs of pyramidal dysfunction and brisk deep-tendon stretch reflexes. Almost all individuals have epilepsy from an early age. The epilepsy is typically well controlled with medication, but status epilepticus occurs relatively frequently. Mental deterioration is late and mild. Disease severity ranges from independent walking for a few years only to independent walking in the fifth decade. Some individuals have died in their teens or twenties; others are alive in their fifties." /><meta name="og:title" content="Megalencephalic Leukoencephalopathy with Subcortical Cysts" /><meta name="og:type" content="book" /><meta name="og:description" content="The classic phenotype of megalencephalic leukoencephalopathy with subcortical cysts (MLC) is characterized by early-onset macrocephaly, often in combination with mild gross motor developmental delay and seizures; gradual onset of ataxia, spasticity, and sometimes extrapyramidal findings; and usually late onset of mild mental deterioration. Macrocephaly, observed in virtually all individuals, may be present at birth but more frequently develops during the first year of life. The degree of macrocephaly is variable and can be as great as 4 to 6 SD above the mean in some individuals. After the first year of life, head growth rate normalizes and growth follows a line parallel to and usually several centimeters above the 98th centile. Initial mental and motor development is normal in most individuals. Walking is often unstable, followed by ataxia of the trunk and extremities, then minor signs of pyramidal dysfunction and brisk deep-tendon stretch reflexes. Almost all individuals have epilepsy from an early age. The epilepsy is typically well controlled with medication, but status epilepticus occurs relatively frequently. Mental deterioration is late and mild. Disease severity ranges from independent walking for a few years only to independent walking in the fifth decade. Some individuals have died in their teens or twenties; others are alive in their fifties." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1535/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mlc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1535/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B934CE04288710000000000410012.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1535_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1535_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mmihs-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/miccap-ms/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1535_"><span class="title" itemprop="name">Megalencephalic Leukoencephalopathy with Subcortical Cysts</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Van der Knaap Disease</div><p class="contrib-group"><span itemprop="author">Marjo S van der Knaap</span>, MD, PhD, <span itemprop="author">Truus EM Abbink</span>, PhD, and <span itemprop="author">Rogier Min</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1535_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1535_ai__"><div class="contrib half_rhythm"><span itemprop="author">Marjo S van der Knaap</span>, MD, PhD<div class="affiliation small">Professor, Department of Pediatrics and Child Neurology<br />VU University Medical Center<br />Amsterdam, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuv@paankrednav.sm" class="oemail">ln.cmuv@paankrednav.sm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Truus EM Abbink</span>, PhD<div class="affiliation small">Assistant Professor, Pediatrics and Child Neurology<br />VU University Medical Center<br />Amsterdam, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuv@knibba.g" class="oemail">ln.cmuv@knibba.g</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Rogier Min</span>, PhD<div class="affiliation small">Assistant Professor, Pediatrics and Child Neurology<br />VU University Medical Center<br />Amsterdam, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuv@nim.r" class="oemail">ln.cmuv@nim.r</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 11, 2003</span>; Last Update: <span itemprop="dateModified">March 29, 2018</span>.</p><p><em>Estimated reading time: 26 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mlc.Summary" itemprop="description"><h2 id="_mlc_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The <i>classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></i> of megalencephalic leukoencephalopathy with subcortical cysts (MLC) is characterized by early-onset macrocephaly, often in combination with mild gross motor developmental delay and seizures; gradual onset of ataxia, spasticity, and sometimes extrapyramidal findings; and usually late onset of mild mental deterioration. Macrocephaly, observed in virtually all individuals, may be present at birth but more frequently develops during the first year of life. The degree of macrocephaly is variable and can be as great as 4 to 6 SD above the mean in some individuals. After the first year of life, head growth rate normalizes and growth follows a line parallel to and usually several centimeters above the 98th centile. Initial mental and motor development is normal in most individuals. Walking is often unstable, followed by ataxia of the trunk and extremities, then minor signs of pyramidal dysfunction and brisk deep-tendon stretch reflexes. Almost all individuals have epilepsy from an early age. The epilepsy is typically well controlled with medication, but status epilepticus occurs relatively frequently. Mental deterioration is late and mild. Disease severity ranges from independent walking for a few years only to independent walking in the fifth decade. Some individuals have died in their teens or twenties; others are alive in their fifties.</p><p>An <i>improving <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></i> has a similar initial presentation with delayed mental or motor development, followed by an improving clinical course: macrocephaly usually persists, but some children become normocephalic; motor function improves or normalizes; hypotonia and clumsiness may persist in some or neurologic examination may become normal. Some have intellectual disability that is stable, with or without autism. Epilepsy and status epilepticus may occur.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of MLC is established in individuals with typical clinical findings and characteristic abnormalities identified on brain MRI examination, including abnormal and swollen cerebral hemispheric white matter and presence of subcortical cysts in the anterior temporal region and often in the frontoparietal region. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MLC1</i> or <i>HEPACAM</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can confirm the diagnosis of classic MLC (MLC1 or MLC2A, respectively) &#x02013; particularly important if clinical features are inconclusive &#x02013; and allow for family studies. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HEPACAM</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can confirm the diagnosis of MLC with improving <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (MLC2B) if clinical features are inconclusive, and/or allow for family studies.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Physical therapy to improve motor function; speech therapy as needed; special education; antiepileptic drugs to control epileptic seizures.</p><p><i>Prevention of secondary complications:</i> A helmet should be considered for situations involving increased risk of head trauma.</p><p><i>Agents/circumstances to avoid:</i> Contact sports and other activities with a high risk of head trauma should be avoided.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>MLC1 and MLC2A are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if both pathogenic alleles have been identified in the family.</p><p>MLC2B is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. <i>De novo</i> pathogenic variants are common. Each child of an individual with MLC2B has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div></div><div id="mlc.Diagnosis"><h2 id="_mlc_Diagnosis_">Diagnosis</h2><div id="mlc.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Two phenotypes are observed in megalencephalic leukoencephalopathy with subcortical cysts (MLC).</p><ul><li class="half_rhythm"><div><b>Classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (includes MLC1 and MLC2A)</b></div><ul><li class="half_rhythm"><div>MLC1, associated with <i>MLC1</i> <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants</div></li><li class="half_rhythm"><div>MLC2A, associated with <i>HEPACAM</i> <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants</div></li></ul></li><li class="half_rhythm"><div><b>Improving <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (includes MLC2B)</b></div><ul><li class="half_rhythm"><div>MLC2B, associated with a <i>HEPACAM</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></div></li></ul></li></ul><p><b>MLC classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> should be suspected</b> in individuals with the following clinical and radiographic features:</p><ul><li class="half_rhythm"><div>Macrocephaly (onset in the first year of life or <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>)</div></li><li class="half_rhythm"><div>Early development normal or mildly delayed</div></li><li class="half_rhythm"><div>Slow deterioration of motor functions with cerebellar ataxia and mild spasticity</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Mental decline (occurs later and is much milder than motor decline)</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Behavioral problems in some individuals</div></li><li class="half_rhythm"><div>Temporary exacerbation of signs and symptoms after minor head trauma</div></li><li class="half_rhythm"><div>On brain MRI (see <a class="figpopup" href="/books/NBK1535/figure/mlc.F1/?report=objectonly" target="object" rid-figpopup="figmlcF1" rid-ob="figobmlcF1">Figure 1</a>):</div><ul><li class="half_rhythm"><div>Cerebral hemispheric white matter is diffusely abnormal and mildly swollen.</div></li><li class="half_rhythm"><div>Central white matter structures, including the corpus callosum, internal capsule, and brain stem, are better preserved than other structures, although they are not usually entirely normal.</div></li><li class="half_rhythm"><div>Cerebellar white matter usually has a mildly abnormal signal and is not swollen.</div></li><li class="half_rhythm"><div>Subcortical cysts are almost invariably present in the anterior temporal region and often in the frontoparietal region.</div></li><li class="half_rhythm"><div>Over time, the white matter swelling decreases and cerebral atrophy ensues. The subcortical cysts may increase in size and number. In some individuals, the cysts become huge, occupying a large part of the frontoparietal white matter. In others, the cerebral white matter abnormalities decrease over time, and the signal intensity of the cerebral white matter becomes less abnormal.</div></li><li class="half_rhythm"><div>Diffusion-weighted imaging reveals increased diffusivity of abnormal white matter [<a class="bk_pop" href="#mlc.REF.itoh.2006.243">Itoh et al 2006</a>, <a class="bk_pop" href="#mlc.REF.van_der_voorn.2006.510">van der Voorn et al 2006</a>].</div></li></ul></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmlcF1" co-legend-rid="figlgndmlcF1"><a href="/books/NBK1535/figure/mlc.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figmlcF1" rid-ob="figobmlcF1"><img class="small-thumb" src="/books/NBK1535/bin/mlc-Image001.gif" src-large="/books/NBK1535/bin/mlc-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndmlcF1"><h4 id="mlc.F1"><a href="/books/NBK1535/figure/mlc.F1/?report=objectonly" target="object" rid-ob="figobmlcF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Brain images of an individual with MLC (A, C) and an unaffected individual (B, D) A. Transverse T<sub>2</sub>-weighted image of a child age nine years with MLC, showing diffusely abnormal and mildly swollen white matter</p></div></div><p><b>MLC improving <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> should be suspected</b> in individuals with the following clinical features:</p><ul><li class="half_rhythm"><div>Macrocephaly (onset in the first year of life or <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> macrocephaly)</div></li><li class="half_rhythm"><div>Early development normal or mildly delayed</div></li><li class="half_rhythm"><div>Motor function improves after the first year of life (clumsiness and hypotonia may persist)</div></li><li class="half_rhythm"><div>Seizures in some individuals</div></li><li class="half_rhythm"><div>Intellectual disability (with or without autism) or normal cognitive function</div></li><li class="half_rhythm"><div>No regression of mental or motor functions</div></li><li class="half_rhythm"><div>Macrocephaly that may persist or may turn into normocephaly</div></li><li class="half_rhythm"><div>On brain MRI:</div><ul><li class="half_rhythm"><div>Findings within the first year of life are similar to those seen in the classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, but cerebellar white matter is usually normal in signal.</div></li><li class="half_rhythm"><div>Striking improvement occurs over time. The MRI may appear normal within a few years, or minor frontal and temporal subcortical white matter abnormalities and anterior temporal cysts may remain.</div></li></ul></li></ul></div><div id="mlc.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of MLC <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above <a href="#mlc.Suggestive_Findings">Suggestive Findings</a>. The characteristic abnormalities on brain MRI examination described in <a href="#mlc.Suggestive_Findings">Suggestive Findings</a> are diagnostic.</p><p>Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MLC1</i> or <i>HEPACAM</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1535/table/mlc.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figmlcTmoleculargenetictestingusedin" rid-ob="figobmlcTmoleculargenetictestingusedin">Table 1</a>) can confirm the diagnosis of classic MLC (MLC1 or MLC2A, respectively) if clinical features are inconclusive, and/or allow for family studies if the diagnosis has been established based on clinical and characteristic radiographic features.</p><p>Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HEPACAM</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can confirm the diagnosis of MLC with improving <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (MLC2B) if clinical features are inconclusive, and/or allow for family studies if the diagnosis has been established based on clinical and characteristic radiographic features.</p><p>Molecular genetic testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b></p><ul><li class="half_rhythm"><div>Sequence analysis of <i>MLC1</i> can be performed first in individuals with the <b>classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></b>, followed by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>HEPACAM</i>. Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>MLC1</i> and <i>HEPACAM</i> can be considered next if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div>Sequence analysis of <i>HEPACAM</i> can be performed first in individuals with the <b>improving <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></b>. Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>HEPACAM</i> can be considered next if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>HEPACAM</i>, <i>MLC1</i>, and other genes of interest (see <a href="#mlc.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="mlc.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Megalencephalic Leukoencephalopathy with Subcortical Cysts</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1535/table/mlc.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mlc.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of MLC Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Method</th></tr><tr><th headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HEPACAM</i></td><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22%&#x000a0;<sup>6</sup></td><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MLC1</i></td><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">76%</td><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">97%</td><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3%&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>9</sup></td><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~2%</td><td headers="hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_mlc.T.molecular_genetic_testing_used_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mlc.TF.1.1"><p class="no_margin">Genes are listed alphabetically.</p></div></dd><dt>2. </dt><dd><div id="mlc.TF.1.2"><p class="no_margin">See <a href="/books/NBK1535/#mlc.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="mlc.TF.1.3"><p class="no_margin">See <a href="#mlc.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="mlc.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="mlc.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="mlc.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al [2011]</a></p></div></dd><dt>7. </dt><dd><div id="mlc.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available. See <a href="#mlc.Molecular_Genetics">Molecular Genetics</a>, <i>MLC1</i>.</p></div></dd><dt>8. </dt><dd><div id="mlc.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#mlc.REF.leegwater.2002.279">Leegwater et al [2002]</a>, <a class="bk_pop" href="#mlc.REF.ilja_boor.2006.505">Ilja Boor et al [2006]</a></p></div></dd><dt>9. </dt><dd><div id="mlc.TF.1.9"><p class="no_margin">In some individuals with clinical features of MLC, pathogenic variants in <i>HEPACAM</i> or <i>MLC1</i> have not been identified [Author, personal observation].</p></div></dd></dl></div></div></div><p><b>Neuropathologic examination.</b> Brain biopsy shows the presence of numerous vacuoles between the outer lamellae of myelin sheaths, suggesting splitting of these lamellae along the intraperiod line or incomplete compaction [<a class="bk_pop" href="#mlc.REF.van_der_knaap.1996.206">van der Knaap et al 1996</a>]. In addition, small vacuoles are observed in astrocytic endfeet [<a class="bk_pop" href="#mlc.REF.duarri.2011.228">Duarri et al 2011</a>].</p></div></div><div id="mlc.Clinical_Characteristics"><h2 id="_mlc_Clinical_Characteristics_">Clinical Characteristics</h2><div id="mlc.Clinical_Description"><h3>Clinical Description</h3><p>The two phenotypes observed in individuals with megalencephalic leukoencephalopathy with subcortical cysts (MLC) include the classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and the improving phenotype. When associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>MLC1</i> pathogenic variants, the classic phenotype is known as MLC1; when caused by biallelic <i>HEPACAM</i> pathogenic variants, MLC is known as MLC2A. The improving phenotype associated with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HEPACAM</i> pathogenic variants is known as MLC2B.</p><div id="mlc.Classic_Phenotype_MLC1_and_MLC2A"><h4>Classic Phenotype (MLC1 and MLC2A)</h4><p><b>Macrocephaly.</b> To date, macrocephaly has been observed in almost all individuals with MLC. Macrocephaly can be present at birth but more frequently develops during the first year of life. The degree of macrocephaly is variable; it may be as great as 4 to 6 SD above the mean in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. After the first year of life, head growth rate normalizes and growth follows a line above and parallel to the 98th centile.</p><p><b>Motor development.</b> Prior to age one year motor development is normal in most infants and mildly delayed in some. Apart from progressive macrocephaly, the first clinical sign is usually a delay in walking. Walking is often unstable, and the child falls frequently. However, most children achieve independent walking. Muscle tone tends to be low, apart from some ankle hypertonia.</p><p>After an interval of several years, slow deterioration of motor function occurs over years with development of ataxia of the trunk and extremities. Signs of pyramidal dysfunction are late and minor and are dominated by the signs of cerebellar ataxia. Speech becomes increasingly dysarthric and dysphagia may develop. Deep-tendon stretch reflexes become brisk and Babinski signs become apparent. Some individuals display extrapyramidal movement abnormalities with dystonia and athetosis. Some individuals develop tics [<a class="bk_pop" href="#mlc.REF.sugiura.2006.286">Sugiura et al 2006</a>].</p><p>Gradually, the ability to walk independently is lost; many children become completely wheelchair dependent at the end of the first decade or in the second decade of life. Some children have a more severe clinical course and maintain their ability to walk independently for only a few years, or never achieve independent walking. Others maintain the ability to walk independently into the fifth decade.</p><p><b>Cognitive development.</b> Initial cognitive development is normal in most children and mildly delayed in some. Intellectual deterioration is late and mild. Decreasing school performance becomes evident during the later years of primary school. In a minority of children, intellectual capacities are mildly decreased in the early years. Some children develop behavior problems [<a class="bk_pop" href="#mlc.REF.sugiura.2006.286">Sugiura et al 2006</a>].</p><p><b>Seizures.</b> Approximately 75% of individuals with classic MLC experience at least one seizure before age 20 years [<a class="bk_pop" href="#mlc.REF.dubey.2018.636">Dubey et al 2018</a>; EMC Hamilton, personal communication]. Seizure onset is typically early, within a few years after birth [EMC Hamilton, personal communication]. Although the epilepsy is most often easily controlled with medication, 15%-20% of individuals experience one or more episodes of status epilepticus, the first of which typically occurs within a few years after seizure onset [<a class="bk_pop" href="#mlc.REF.dubey.2018.636">Dubey et al 2018</a>]. Seizures and status epilepticus are frequently precipitated by minor head trauma.</p><p><b>Minor head trauma</b> may induce temporary deterioration in some individuals, most often observed as seizures or status epilepticus, prolonged unconsciousness, or acute motor deterioration with gradual improvement [<a class="bk_pop" href="#mlc.REF.bugiani.2003.211">Bugiani et al 2003</a>, <a class="bk_pop" href="#mlc.REF.dubey.2018.636">Dubey et al 2018</a>].</p><p><b>Prognosis.</b> Some children have a more benign clinical course and, even as teenagers, have macrocephaly only. Individuals who are ambulatory with or without support at age 15 years are most likely to remain ambulatory [EMC Hamilton, personal communication]. Because the disease has been known for a relatively short time, information regarding average life span is very limited. Some individuals have died in their teens or twenties; others are alive in their fifties.</p></div><div id="mlc.Improving_Phenotype_MLC2B"><h4>Improving Phenotype (MLC2B)</h4><p>In children diagnosed with MLC2B the initial disease course is the same as that in children with the classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>: mental and motor development is normal in most and mildly delayed in some.</p><p><b>Macrocephaly</b> is present at birth or (more commonly) develops within the first year of life in 90% of individuals. In individuals with the improving <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, head circumference is initially equally large. After the first year of life, growth of the head usually either decreases or follows a line above and parallel to the 98th centile. In 40%-50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children, the head circumference normalizes [EMC Hamilton, personal communication].</p><p><b>Motor development.</b> Apart from progressive macrocephaly, the first clinical sign is usually delay in walking. Walking is often unstable, and the child falls frequently. All children achieve independent walking. After the second or third year of life, motor function improves or normalizes in most. Neurologic examination may become normal, but some children have persistent hypotonia and clumsiness. Regression does not occur.</p><p><b>Cognitive function</b> is normal in approximately 75% of individuals; 25% have mild intellectual disability [EMC Hamilton, personal communication]. Autism is observed in 25% of individuals. Regression has not been observed.</p><p><b>Seizures.</b> Epilepsy and status epilepticus may occur, but 90% of individuals have no history of seizures [EMC Hamilton, personal communication].</p><p><b>Prognosis.</b> Because the disease has been known for a relatively short time, information regarding average life span is very limited. Considering the normal health of parents <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a dominant <i>HEPACAM</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, it does not appear that MLC2B-related <i>HEPACAM</i> pathogenic variants shorten life span; however, no formal study has addressed this issue. One child died in status epilepticus at age three years [EMC Hamilton, personal communication].</p><p>In families with <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from more than one generation, the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is usually a child and the affected parent is subsequently diagnosed. Parents with the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> often have macrocephaly but normal motor and cognitive function. Some parents have cognitive or behavioral problems or motor clumsiness.</p></div></div><div id="mlc.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p><b>Classic MLC.</b> A review of 17 individuals with MLC2A (<a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <b><i>HEPACAM</i></b> pathogenic variants) revealed no phenotypic differences from individuals with MLC1 who have identifiable biallelic pathogenic variants in <b><i>MLC1</i></b> [Hamilton et al, unpublished].</p></div><div id="mlc.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b><i>MLC1</i>.</b> A review of 187 individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>MLC1</i> pathogenic variants revealed that in individuals from the same family, disease severity and clinical course can vary significantly [EMC Hamilton, personal communication]. There is no known <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation.</p><p><b><i>HEPACAM</i>.</b> All known MLC-related <i>HEPACAM</i> pathogenic variants affect the extracellular part of the protein and not its transmembrane and intracellular part, independent of whether they have dominant or recessive effects [<a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</a>]. Recessive <i>HEPACAM</i> pathogenic variants are spread over the entire extracellular region of the protein; dominant pathogenic variants are clustered in the first immunoglobulin <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</a>]. Dominant and recessive pathogenic variants do not overlap, although they may affect the same residue [<a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</a>]. At present, it is unclear why some <i>HEPACAM</i> pathogenic variants have recessive inheritance and others dominant inheritance.</p></div><div id="mlc.Penetrance"><h3>Penetrance</h3><p><b>MLC2B.</b> The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of dominant <i>HEPACAM</i> pathogenic variants is reduced. The proportion of individuals with a pathogenic <i>HEPACAM</i> variant who exhibit or have exhibited clinical manifestations of MLC2B is not known. There is no evidence of a difference in penetrance based on sex.</p></div><div id="mlc.Nomenclature"><h3>Nomenclature</h3><p>Names previously used for MLC:</p><ul><li class="half_rhythm"><div>Leukoencephalopathy with swelling and a discrepantly mild course</div></li><li class="half_rhythm"><div>Leukoencephalopathy with swelling and cysts</div></li><li class="half_rhythm"><div>Infantile leukoencephalopathy and megalencephaly</div></li><li class="half_rhythm"><div>Vacuolating leukoencephalopathy</div></li></ul></div><div id="mlc.Prevalence"><h3>Prevalence</h3><p>Megalencephalic leukoencephalopathy with subcortical cysts is a rare disorder with a low <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> in the general population. Consequently, the disease is rarer in communities with a low rate of <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> and higher in communities with a high rate of consanguinity (e.g., see <a class="bk_pop" href="#mlc.REF.top_u.1998.142">Top&#x000e7;u et al [1998]</a>). The parents of many individuals with classic megalencephalic leukoencephalopathy with subcortical cysts are <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a>.</p><ul><li class="half_rhythm"><div>Almost all East Indian individuals with MLC1 belong to the Agrawal community; and all individuals within this community are <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> for the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK1535/table/mlc.T.mlc1_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figmlcTmlc1pathogenicvariantsdiscussed" rid-ob="figobmlcTmlc1pathogenicvariantsdiscussed">c.135dupC</a>), providing evidence for a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> [<a class="bk_pop" href="#mlc.REF.leegwater.2002.279">Leegwater et al 2002</a>, <a class="bk_pop" href="#mlc.REF.singhal.2003.646">Singhal et al 2003</a>, <a class="bk_pop" href="#mlc.REF.gorospe.2004.878">Gorospe et al 2004</a>].</div></li><li class="half_rhythm"><div>MLC1 is also relatively common among Libyan Jews [<a class="bk_pop" href="#mlc.REF.benzeev.2001.93">Ben-Zeev et al 2001</a>]. One common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK1535/table/mlc.T.mlc1_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figmlcTmlc1pathogenicvariantsdiscussed" rid-ob="figobmlcTmlc1pathogenicvariantsdiscussed">c.176G&#x0003e;A</a>) was found in five unrelated Libyan Jewish families [<a class="bk_pop" href="#mlc.REF.benzeev.2002.214">Ben-Zeev et al 2002</a>]. The same variant was identified in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from a single Turkish Jewish family descended from the same ancestors. Screening of 200 normal Libyan Jewish individuals for this particular pathogenic variant revealed a <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> of one in 40, as compared with an expected carrier rate of one in 81. Non-Jewish Turkish individuals do not share a common pathogenic variant.</div></li><li class="half_rhythm"><div>The <i>MLC1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1535/table/mlc.T.mlc1_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figmlcTmlc1pathogenicvariantsdiscussed" rid-ob="figobmlcTmlc1pathogenicvariantsdiscussed">c.278C&#x0003e;T</a> appears to be common in Japanese individuals [<a class="bk_pop" href="#mlc.REF.shimada.2014.14019">Shimada et al 2014</a>] but has also been observed in Finland, Turkey [<a class="bk_pop" href="#mlc.REF.leegwater.2001.831">Leegwater et al 2001</a>], and Italy [<a class="bk_pop" href="#mlc.REF.montagna.2006.292">Montagna et al 2006</a>].</div></li><li class="half_rhythm"><div>Among Egyptians with MLC, the <i>MLC1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1535/table/mlc.T.mlc1_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figmlcTmlc1pathogenicvariantsdiscussed" rid-ob="figobmlcTmlc1pathogenicvariantsdiscussed">c.908_918delinsGCA</a> is common and <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals share a haplotype, indicating a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> [<a class="bk_pop" href="#mlc.REF.abdelsalam.2016.1171">Abdel-Salam et al 2016</a>].</div></li><li class="half_rhythm"><div>In Korea, <a class="figpopup" href="/books/NBK1535/table/mlc.T.mlc1_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figmlcTmlc1pathogenicvariantsdiscussed" rid-ob="figobmlcTmlc1pathogenicvariantsdiscussed">c.824C&#x0003e;A</a> accounted for 70% of alleles in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals were [<a class="bk_pop" href="#mlc.REF.choi.2017.516">Choi et al 2017</a>].</div></li></ul></div></div><div id="mlc.Genetically_Related_Allelic_Disorder"><h2 id="_mlc_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>Associations of <i>MLC1</i> variants with catatonic schizophrenia have been reported, but whether they have a role in development of this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> remains to be determined [<a class="bk_pop" href="#mlc.REF.meyer.2001.302">Meyer et al 2001</a>, <a class="bk_pop" href="#mlc.REF.devaney.2002.419">Devaney et al 2002</a>, <a class="bk_pop" href="#mlc.REF.rubie.2003.45">Rubie et al 2003</a>, <a class="bk_pop" href="#mlc.REF.kaganovich.2004.31">Kaganovich et al 2004</a>, <a class="bk_pop" href="#mlc.REF.verma.2005.16">Verma et al 2005</a>, <a class="bk_pop" href="#mlc.REF.selch.2007.1211">Selch et al 2007</a>, <a class="bk_pop" href="#mlc.REF.spijker.2010.179">Spijker et al 2010</a>, <a class="bk_pop" href="#mlc.REF.balestri.2017.98">Balestri et al 2017</a>].</p></div><div id="mlc.Differential_Diagnosis"><h2 id="_mlc_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of macrocephaly and a diffuse leukoencephalopathy is limited; it includes Canavan disease, Alexander disease, infantile-onset GM2 gangliosidosis, and, on occasion, infantile-onset GM1 gangliosidosis and L-2-hydroxyglutaric aciduria. Some children with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy caused by laminin alpha-2 (merosin) deficiency (also known as MDC1A) have macrocephaly. The clinical features and course of these disorders are usually different from those of MLC. If the head circumference is well within the normal limits at age one year, it is highly unlikely that the infant has MLC. None of these disorders shares all the MRI characteristics of megalencephalic leukoencephalopathy with subcortical cysts (MLC).</p><div id="mlc.T.disorders_to_consider_in_the_diffe" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of MLC</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1535/table/mlc.T.disorders_to_consider_in_the_diffe/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mlc.T.disorders_to_consider_in_the_diffe_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4" id="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/MLC</th><th headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4" id="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from MLC</th></tr></thead><tbody><tr><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Laminin alpha 2 deficiency</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LAMA2</i></td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Similar cerebral WM disease w/swelling of the abnormal WM</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Usually lacking the typical subcortical cysts seen in MLC</div></li><li class="half_rhythm"><div>Prominent weakness &#x00026; hypotonia (not seen in MLC)</div></li></ul></td></tr><tr><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/canavan/">Canavan disease</a></td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ASPA</i></td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Similar cerebral WM disease w/swelling of the abnormal WM</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>In some cases: WM abnormalities limited to the directly subcortical WM</div></li><li class="half_rhythm"><div>Typically on MRI: involvement of the thalamus &#x00026; globus pallidus w/relative sparing of a bilateral crescent formed by the putamen &#x00026; caudate nucleus (The globus pallidus &#x00026; thalamus are not involved in MLC.)</div></li><li class="half_rhythm"><div>Lacking the typical subcortical cysts seen in MLC</div></li></ul></td></tr><tr><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alexander/">Alexander disease</a></td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GFAP</i></td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Similar WM disease w/swelling of the abnormal WM</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Frontal predominance of MRI abnormalities (Predilection for the anterior parts of the brain is less clear in MLC.)</div></li><li class="half_rhythm"><div>Mild signal abnormalities of basal ganglia &#x00026; thalami (not seen in MLC)</div></li><li class="half_rhythm"><div>Contrast enhancement of particular brain structures almost invariably seen (not seen in MLC)</div></li><li class="half_rhythm"><div>Cysts usually located in deep frontal WM (different from MLC)</div></li><li class="half_rhythm"><div>Typical involvement of brain stem structures (signal abnormalities, tumor-like structures, atrophy) (not seen in MLC)</div></li></ul></td></tr><tr><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">L-2-hydroxyglutaric aciduria (OMIM <a href="http://omim.org/entry/236792" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">236792</a>)</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>L2HGDH</i></td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Similar WM disease w/swelling of the abnormal WM</td><td headers="hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_mlc.T.disorders_to_consider_in_the_diffe_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cerebral WM abnormalities in some cases limited to the directly subcortical WM</div></li><li class="half_rhythm"><div>Cerebral WM abnormalities multifocal in some cases (invariably diffuse in MLC)</div></li><li class="half_rhythm"><div>Typicially on MRI: involvement of the basal nuclei (not seen in MLC)</div></li><li class="half_rhythm"><div>Dentate nucleus typically prominently <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (not in MLC)</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; WM = white matter</p></div></dd></dl></div></div></div><p>See <a href="https://omim.org/phenotypicSeries/PS604004" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM Phenotypic Series: Leukoencephalopathy, megalencephalic</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div><div id="mlc.Management"><h2 id="_mlc_Management_">Management</h2><div id="mlc.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with megalencephalic leukoencephalopathy with subcortical cysts (MLC) the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Brain MRI examination</div></li><li class="half_rhythm"><div>Physical therapy / occupational therapy assessment</div></li><li class="half_rhythm"><div>Assessment of cognitive function (neuropsychological testing)</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="mlc.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Supportive therapy includes the following:</p><ul><li class="half_rhythm"><div>Physical therapy to improve motor function</div></li><li class="half_rhythm"><div>Speech therapy as needed</div></li><li class="half_rhythm"><div>Special education</div></li><li class="half_rhythm"><div>Antiepileptic drugs if epileptic seizures are present</div></li></ul></div><div id="mlc.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>If patients have epilepsy, treatment with antiepileptic drugs should be considered.</p><p>Minor head trauma may lead to temporary motor deterioration, seizures, or (rarely) coma. Wearing of a helmet should be considered for situations involving increased risk of head trauma.</p></div><div id="mlc.Surveillance"><h3>Surveillance</h3><p>There are no published guidelines for surveillance. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are reevaluated in neurology clinics annually to document disease progression and determine if other interventions are necessary. For some patients more frequent visits are needed to treat the epilepsy.</p><p>Initially, annual MRI may be considered to monitor disease development, while eventually one MRI every five years should suffice because of the slow disease course.</p></div><div id="mlc.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Minor head trauma may lead to temporary motor deterioration, seizures, or (rarely) to coma. For this reason, contact sports and other activities with a high risk of head trauma should be avoided.</p></div><div id="mlc.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#mlc.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="mlc.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Potential teratogenic effects of antiepileptic drugs should be discussed with <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women of childbearing age, ideally prior to conception.</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for more information on medication use during pregnancy.</p></div><div id="mlc.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="mlc.Other"><h3>Other</h3><p>Unsuccessful therapies have included diuretics, acetazolamide, and creatine monohydrate.</p></div></div><div id="mlc.Genetic_Counseling"><h2 id="_mlc_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="mlc.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of megalencephalic leukoencephalopathy with subcortical cysts (MLC) caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MLC1</i> (known as MLC1) or by biallelic pathogenic variants <i>HEPACAM</i> (known as MLC2A) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p>The improving <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of MLC caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>HEPACAM</i> (known as MLC2B) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p>Note: <i>HEPACAM</i> pathogenic variants associated with dominant inheritance do not overlap with <i>HEPACAM</i> pathogenic variants associated with recessive inheritance (see <a href="#mlc.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</a>).</p></div><div id="mlc.Risk_to_Family_Members__Autosomal_Re"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance (MLC1 and MLC2A)</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are typically heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>); in rare cases, only one parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and a second pathogenic variant arose <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> [<a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</a>].</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic. No clinical or MRI abnormalities have been found in individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for MLC1- or MLC2A-related pathogenic variants.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>If both parents are carriers, at conception, each sib of an individual with MLC1 or MLC2A has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Intrafamilial variability has been observed in MLC1.</div></li><li class="half_rhythm"><div>If only one parent is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> for an MLC1- or MLC2A-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, at conception, each sib has a 50% chance of being an asymptomatic carrier and a 50% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder. No clinical or MRI abnormalities have been found in individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an MLC1- or MLC2A-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p><div id="mlc.Carrier_Heterozygote_Detection"><h4>Carrier (Heterozygote) Detection</h4><p>Carrier testing for at-risk relatives requires prior identification of the MLC1- or MLC2A-related pathogenic variants in the family.</p></div></div><div id="mlc.Risk_to_Family_Members__Autosomal_Do"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance (MLC2B)</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Many individuals with MLC2B have a parent with macrocephaly. Given the neurologic improvement that is observed in this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, the parent is not at risk of neurologic regression. Whether having a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HEPACAM</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> leads to other symptoms late in life has not been investigated; however, to date no evidence suggests disease progression later in life.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with MLC2B may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is approximately 20%.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, two possible explanations are a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with MLC2B may appear to be negative because of failure to recognize the disorder in family members, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, or milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to have the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>If the MLC2B-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#mlc.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the MLC2B-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the sibs are still at increased risk for MLC2B because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with MLC2B has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the MLC2B-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="mlc.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="mlc.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for MLC are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="mlc.Resources"><h2 id="_mlc_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>European Leukodystrophy Association (ELA)</b></div><div>2, rue Mi-les-Vignes</div><div>B.P. 61024</div><div>Laxou Cedex 54521</div><div>France</div><div><b>Phone:</b> 03833093 34</div><div><b>Fax:</b> 03833000 68</div><div><b>Email:</b> ela@ela-asso.com</div><div><a href="http://www.ela-asso.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ela-asso.com</a></div></li><li class="half_rhythm"><div><b>Leukodystrophy Australia</b></div><div>P O Box 2550</div><div>Mount Waverley Victoria 3149</div><div>Australia</div><div><b>Phone:</b> 1800-141-400 (toll free)</div><div><b>Email:</b> info@leuko.org.au</div><div><a href="http://www.leuko.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.leuko.org.au</a></div></li><li class="half_rhythm"><div><b>United Leukodystrophy Foundation (ULF)</b></div><div>224 North Second Street</div><div>Suite 2</div><div>DeKalb IL 60115</div><div><b>Phone:</b> 800-728-5483 (toll-free); 815-748-3211</div><div><b>Fax:</b> 815-748-0844</div><div><b>Email:</b> office@ulf.org</div><div><a href="http://www.ulf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ulf.org</a></div></li><li class="half_rhythm"><div><b>Myelin Disorders Bioregistry Project</b></div><div><b>Email:</b> myelindisorders@cnmc.org</div><div><a href="https://www.chop.edu/research/myelin-disorders-biorepository-project" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myelin Disorders Bioregistry Project</a></div></li></ul></div><div id="mlc.Molecular_Genetics"><h2 id="_mlc_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="mlc.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Megalencephalic Leukoencephalopathy with Subcortical Cysts: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1535/table/mlc.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mlc.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_mlc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_mlc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_mlc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_mlc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_mlc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_mlc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_mlc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/220296" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HEPACAM</i></a></td><td headers="hd_b_mlc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=220296" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q24<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_mlc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q14CZ8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hepatocyte cell adhesion molecule</a></td><td headers="hd_b_mlc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_mlc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HEPACAM" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HEPACAM</a></td><td headers="hd_b_mlc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HEPACAM[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HEPACAM</a></td></tr><tr><td headers="hd_b_mlc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/23209" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MLC1</i></a></td><td headers="hd_b_mlc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=23209" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q13<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_mlc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q15049" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Membrane protein MLC1</a></td><td headers="hd_b_mlc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/MLC1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MLC1 database</a></td><td headers="hd_b_mlc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MLC1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MLC1</a></td><td headers="hd_b_mlc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MLC1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MLC1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="mlc.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="mlc.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Megalencephalic Leukoencephalopathy with Subcortical Cysts (<a href="/omim/604004,605908,611642,613925,613926" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1535/table/mlc.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mlc.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604004" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604004</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605908" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605908</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MLC1 GENE; MLC1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611642" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611642</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HEPATOCYTE CELL ADHESION MOLECULE; HEPACAM</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613925" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613925</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613926" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613926</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B</td></tr></tbody></table></div></div><p><b><i>MLC1</i></b></p><p><b>Gene structure.</b>
<i>MLC1</i> comprises 26,214 bases and 13 exons; the <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> has 3,435 base pairs. <i>MLC1</i> is mainly expressed in the brain but also in all types of leukocytes. Within the brain, MLC1 is exclusively expressed in astrocytic endfeet. The highest levels have been found within the brain in the caudate nucleus, thalamus, and hippocampus. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1535/#mlc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 100 variants in <i>MLC1</i> have been associated with disease. Approximately 50% of <i>MLC1</i> pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, 28% are frameshifts caused by <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>, 22% are in a splice junction, and one (out of 50) is a <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant [<a class="bk_pop" href="#mlc.REF.ilja_boor.2006.505">Ilja Boor et al 2006</a>, <a class="bk_pop" href="#mlc.REF.van_der_knaap.2012.973">van der Knaap et al 2012</a>, <a class="bk_pop" href="#mlc.REF.kariminejad.2015.71">Kariminejad et al 2015</a>, <a class="bk_pop" href="#mlc.REF.cao.2016.e0157258">Cao et al 2016</a>]. (For more information, see <a href="/books/NBK1535/#mlc.molgen.TA">Table A</a>.) Deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> pathogenic variants as well as multiexon deletions have been detected by analysis (<a class="figpopup" href="/books/NBK1535/table/mlc.T.mlc1_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figmlcTmlc1pathogenicvariantsdiscussed" rid-ob="figobmlcTmlc1pathogenicvariantsdiscussed">Table 3</a>, footnotes 2 and 3).</p><div id="mlc.T.mlc1_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>MLC1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1535/table/mlc.T.mlc1_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mlc.T.mlc1_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.135dupC&#x000a0;<sup>1</sup></td><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys46LeufsTer34</td><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=93141206" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015166<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=14589896" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055981<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.176G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly59Glu</td></tr><tr><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.178-10T&#x0003e;A&#x000a0;<sup>2</sup></td><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser60_Ser89del</td></tr><tr><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.278C&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser93Leu</td></tr><tr><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.298_423+108del&#x000a0;<sup>3</sup></td><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr99fsTer</td></tr><tr><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.824C&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala275Asp</td></tr><tr><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.908_918delinsGCA&#x000a0;<sup>1</sup></td><td headers="hd_h_mlc.T.mlc1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.V303GfsTer96</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="mlc.TF.3.1"><p class="no_margin">See <a href="#mlc.Prevalence">Prevalence</a>.</p></div></dd><dt>2. </dt><dd><div id="mlc.TF.3.2"><p class="no_margin">Causes complete skipping <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 [<a class="bk_pop" href="#mlc.REF.ilja_boor.2006.505">Ilja Boor et al 2006</a>, <a class="bk_pop" href="#mlc.REF.van_der_knaap.2012.973">van der Knaap et al 2012</a>]</p></div></dd><dt>3. </dt><dd><div id="mlc.TF.3.3"><p class="no_margin">Describes the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 126 nucleotides in an <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and deletion of 108 additional nucleotides after base 423, which is at a splice donor site. The total deletion of exon and <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> sequences is 234 nucleotides [<a class="bk_pop" href="#mlc.REF.ilja_boor.2006.505">Ilja Boor et al 2006</a>].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The MLC1 protein is 377 amino acids; its predicted molecular weight is 41 kd. MLC1 is an integral membrane protein (<a href="http://www.kazusa.or.jp/huge/gfpage/KIAA0027/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HUGE Protein Database</a>) of unknown function. The protein is localized mainly in the endfeet of astrocytes in the perivascular, subependymal, and subpial regions. The localization of the protein, combined with the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of MLC, suggests a role for MLC1 in brain ion and water homeostasis [<a class="bk_pop" href="#mlc.REF.van_der_knaap.2012.973">van der Knaap et al 2012</a>]. The MLC1 protein shares its endfeet localization with members of the dystrophin glycoprotein-associated complex [<a class="bk_pop" href="#mlc.REF.boor.2007.403">Boor et al 2007</a>] and has been shown to interact with a variety of proteins potentially involved in brain ion and water homeostasis. These include, among others, the Na+/K+-ATPase, TRPV4, caveolin-1, and Kir4.1 [<a class="bk_pop" href="#mlc.REF.brignone.2015.66">Brignone et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<a class="bk_pop" href="#mlc.REF.teijido.2004.2581">Teijido et al [2004]</a> and <a class="bk_pop" href="#mlc.REF.montagna.2006.292">Montagna et al [2006]</a> examined <i>MLC1</i> pathogenic variants by measuring the protein expression and the amount of protein at the plasma membrane. All tested <i>MLC1</i> pathogenic variants showed a low steady-state expression of MLC1 with a consequent reduction in surface expression. Electrophysiologic experiments reveal a reduction of volume-regulated anion channel (VRAC) activity in lymphoblasts from individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>MLC1</i> pathogenic variants. This results in impaired regulatory volume decrease (RVD) upon hypotonic cell swelling [<a class="bk_pop" href="#mlc.REF.ridder.2011.3342">Ridder et al 2011</a>]. Cell lines overexpressing normal MLC1 show enhanced VRAC activity, which is absent upon overexpression of mutated MLC1 in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#mlc.REF.ridder.2011.3342">Ridder et al 2011</a>]. This is in line with a role for MLC1 in VRAC regulation.</p><p><b>Animal models.</b>
<i>Mlc1</i>-null mice recapitulate important disease features including increased brain water content and progressive white matter vacuolization [<a class="bk_pop" href="#mlc.REF.hoeggbeiler.2014.3475">Hoegg-Beiler et al 2014</a>, <a class="bk_pop" href="#mlc.REF.dubey.2015.114">Dubey et al 2015</a>]. Study of these mice reveals that swelling of perivascular astrocyte endfeet occurs early in the disease, before widespread myelin vacuolization. Disrupted VRAC activity and disturbed RVD are observed in <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> astrocytes prepared from <i>Mlc1</i>-null mice [<a class="bk_pop" href="#mlc.REF.dubey.2015.114">Dubey et al 2015</a>]. In rat primary astrocytes, reduction of MLC1 expression resulted in the appearance of intracellular vacuoles [<a class="bk_pop" href="#mlc.REF.duarri.2011.228">Duarri et al 2011</a>].</p><p><b><i>HEPACAM</i></b></p><p><b>Gene structure.</b>
<i>HEPACAM</i> comprises 17,076 bases and seven exons. The <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> has 3,563 base pairs. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1535/#mlc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<i>HEPACAM</i> pathogenic variants leading to the classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (MLC2A) are mostly <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> (e.g., c.292C&#x0003e;T); however, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frameshift variants have also been observed. In the case of the improving phenotype (MLC2B), only missense variants in <i>HEPACAM</i> have been reported [<a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</a>, <a class="bk_pop" href="#mlc.REF.van_der_knaap.2012.973">van der Knaap et al 2012</a>].</p><p>The most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in MLC2B (6 of 16 cases in <a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al [2011]</a>) is the pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant p.Gly89Ser. Another common variant is p.Arg92Trp [<a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</a>], which occurs in the same codon as the MLC2A-associated p.Arg92Gln. See <a class="figpopup" href="/books/NBK1535/table/mlc.T.hepacam_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figmlcThepacampathogenicvariantsdiscus" rid-ob="figobmlcThepacampathogenicvariantsdiscus">Table 4</a>.</p><div id="mlc.T.hepacam_pathogenic_variants_discus" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>HEPACAM</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1535/table/mlc.T.hepacam_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mlc.T.hepacam_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MLC Type</th><th id="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>MLC2A</b></td><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.275G&#x0003e;A</td><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">p.Arg92Gln</td><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_4" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_152722.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_152722<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_689935.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_689935<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.292C&#x0003e;T</td><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">p.Arg98Cys</td></tr><tr><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>MLC2B</b></td><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.265G&#x0003e;A</td><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly89Ser</td></tr><tr><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.274C&#x0003e;T</td><td headers="hd_h_mlc.T.hepacam_pathogenic_variants_discus_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg92Trp</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The size of the protein encoded by <i>HEPACAM</i>, the hepatic and glial cell adhesion molecule (called either HepaCAM or GlialCAM) [<a class="bk_pop" href="#mlc.REF.chung_moh.2005.833">Chung Moh et al 2005</a>, <a class="bk_pop" href="#mlc.REF.favrekontula.2008.633">Favre-Kontula et al 2008</a>], is 417 amino acids; its predicted molecular weight is 46 kd. GlialCAM is a single transmembrane protein with two extracellular immunoglobulin domains. Although originally identified in hepatocellular carcinoma cell lines (hence its name HepaCAM), it is predominantly expressed in the brain. GlialCAM colocalizes with MLC1 in astrocyte endfeet. However, GlialCAM expression is not restricted to astrocytes; it is also present in axons, on the outside of myelin sheaths, and in oligodendrocytes [<a class="bk_pop" href="#mlc.REF.favrekontula.2008.633">Favre-Kontula et al 2008</a>, <a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</a>]. GlialCAM acts as a chaperone for MLC1, ensuring the localization of both proteins at astrocyte-astrocyte junctions in endfeet and in cultured astrocytes [<a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</a>, <a class="bk_pop" href="#mlc.REF.capdevilanortes.2013.4405">Capdevila-Nortes et al 2013</a>]. In addition, GlialCAM acts as an auxiliary subunit for the chloride channel ClC-2. It increases ClC-2 mediated currents, changes their functional properties, and is necessary for ClC-2 localization to astrocyte-astroycte junctions [<a class="bk_pop" href="#mlc.REF.jeworutzki.2012.951">Jeworutzki et al 2012</a>, <a class="bk_pop" href="#mlc.REF.hoeggbeiler.2014.3475">Hoegg-Beiler et al 2014</a>]. GlialCAM also interacts with the gap junction subunit connexin 43 [<a class="bk_pop" href="#mlc.REF.wu.2016.36218">Wu et al 2016</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> All MLC-causing variants in <i>HEPACAM</i> affect the extracellular region of GlialCAM. In cultured rat primary astrocytes, mutated GlialCAM with either a dominant or a recessive <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> disrupts localization of MLC1 and GlialCAM at astrocyte-astrocyte junctions. Coexpression of wild type GlialCAM rescues the detrimental effect of GlialCAM with a recessive variant on MLC1 localization, but it does not rescue the effect of the dominant variant of GlialCAM [<a class="bk_pop" href="#mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</a>]. Biochemical analysis shows that some dominant and recessive pathogenic variants disrupt the ability of GlialCAM to homo-oligomerize [<a class="bk_pop" href="#mlc.REF.arnedo.2014.1175">Arnedo et al 2014</a>]. However, what causes a <i>HEPACAM</i> variant to be dominant vs recessive is still unclear.</p><p><b>Animal models.</b> Similar to <i>Mlc1</i>-null mice, <i>Glialcam-</i>null mice as well as mice <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a dominant <i>Glialcam</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> recapitulate important features of MLC such as increased brain water content, astrocyte swelling, and progressive myelin vacuolization [<a class="bk_pop" href="#mlc.REF.hoeggbeiler.2014.3475">Hoegg-Beiler et al 2014</a>, <a class="bk_pop" href="#mlc.REF.bugiani.2017.450">Bugiani et al 2017</a>]. In rat primary astrocytes, reduction of GlialCAM expression results in the appearance of intracellular vacuoles and disrupts VRAC activity [<a class="bk_pop" href="#mlc.REF.capdevilanortes.2013.4405">Capdevila-Nortes et al 2013</a>].</p></div><div id="mlc.References"><h2 id="_mlc_References_">References</h2><div id="mlc.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.abdelsalam.2016.1171">Abdel-Salam GM, Abdel-Hamid MS, Ismail SI, Hosny H, Omar T, Effat L, Aglan MS, Temtamy SA, Zaki MS. Megalencephalic leukoencephalopathy with cysts in twelve Egyptian patients: novel mutations in MLC1 and HEPACAM and a founder effect. <span><span class="ref-journal">Metab Brain Dis. </span>2016;<span class="ref-vol">31</span>:1171–9.</span> [<a href="/pubmed/27389245" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27389245</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.arnedo.2014.1175">Arnedo T, L&#x000f3;pez-Hern&#x000e1;ndez T, Jeworutzki E, Capdevila-Nortes X, Sirisi S, Pusch M, Est&#x000e9;vez R. Functional analyses of mutations in HEPACAM causing megalencephalic leukoencephalopathy. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:1175–8.</span> [<a href="/pubmed/25044933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25044933</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.balestri.2017.98">Balestri M, Crisafulli C, Donato L, Giegling I, Calati R, Antypa N, Schneider B, Marusic D, Tarozzi ME, Marusic D, Paragi M, Hartmann AM, Konte B, Marsano A, Serretti A, Rujescu D. Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls. <span><span class="ref-journal">J Psychiatr Res. </span>2017;<span class="ref-vol">91</span>:98–104.</span> [<a href="/pubmed/28327445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28327445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.benzeev.2001.93">Ben-Zeev B, Gross V, Kushnir T, Shalev R, Hoffman C, Shinar Y, Pras E, Brand N. Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients. <span><span class="ref-journal">J Child Neurol. </span>2001;<span class="ref-vol">16</span>:93–9.</span> [<a href="/pubmed/11292232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11292232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.benzeev.2002.214">Ben-Zeev B, Levy-Nissenbaum E, Lahat H, Anikster Y, Shinar Y, Brand N, Gross-Tzur V, MacGregor D, Sidi R, Kleta R, Frydman M, Pras E. Megalencephalic leukoencephalopathy with subcortical cysts; a founder effect in Israeli patients and a higher than expected carrier rate among Libyan Jews. <span><span class="ref-journal">Hum Genet. </span>2002;<span class="ref-vol">111</span>:214–8.</span> [<a href="/pubmed/12189496" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12189496</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.boor.2007.403">Boor I, Nagtegaal M, Kamphorst W, van der Valk P, Pronk JC, van Horssen J, Dinopoulos A, Bove KE, Pascual-Castroviejo I, Muntoni F, Est&#x000e9;vez R, Scheper GC, van der Knaap MS. MLC1 is associated with the dystrophin-glycoprotein complex at astrocytic endfeet. <span><span class="ref-journal">Acta Neuropathol. </span>2007;<span class="ref-vol">114</span>:403–10.</span> [<a href="/pmc/articles/PMC2039857/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2039857</span></a>] [<a href="/pubmed/17628813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17628813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.brignone.2015.66">Brignone MS, Lanciotti A, Camerini S, De Nuccio C, Petrucci TC, Visentin S, Ambrosini E. MLC1 protein: a likely link between leukodystrophies and brain channelopathies. <span><span class="ref-journal">Front Cell Neurosci. </span>2015;<span class="ref-vol">9</span>:66.</span> [<a href="/pmc/articles/PMC4381631/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4381631</span></a>] [<a href="/pubmed/25883547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25883547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.bugiani.2017.450">Bugiani M, Dubey M, Breur M, Postma NL, Dekker MP, Ter Braak T, Boschert U, Abbink TEM, Mansvelder HD, Min R, van Weering JRT, van der Knaap MS. Megalencephalic leukoencephalopathy with cysts: the <em>Glialcam</em>-null mouse model. <span><span class="ref-journal">Ann Clin Transl Neurol. </span>2017;<span class="ref-vol">4</span>:450–65.</span> [<a href="/pmc/articles/PMC5497535/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5497535</span></a>] [<a href="/pubmed/28695146" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28695146</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.bugiani.2003.211">Bugiani M, Moroni I, Bizzi A, Nardocci N, Bettecken T, G&#x000e4;rtner J, Uziel G. Consciousness disturbances in megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">Neuropediatrics. </span>2003;<span class="ref-vol">34</span>:211–4.</span> [<a href="/pubmed/12973663" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12973663</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.cao.2016.e0157258">Cao B, Yan H, Guo M, Xie H, Wu Y, Gu Q, Xiao J, Shang J, Yang Y, Xiong H, Niu Z, Wu X, Jiang Y, Wang J. Ten novel mutations in Chinese patients with megalencephalic leukoencephalopathy with subcortical cysts and a long-term follow-up research. <span><span class="ref-journal">PLoS One. </span>2016;<span class="ref-vol">11</span>:e0157258.</span> [<a href="/pmc/articles/PMC4913951/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4913951</span></a>] [<a href="/pubmed/27322623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27322623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.capdevilanortes.2013.4405">Capdevila-Nortes X, L&#x000f3;pez-Hern&#x000e1;ndez T, Apaja PM, L&#x000f3;pez de Heredia M, Sirisi S, Callejo G, Arnedo T, Nunes V, Lukacs GL, Gasull X, Est&#x000e9;vez R. Insights into MLC pathogenesis: GlialCAM is an MLC1 chaperone required for proper activation of volume-regulated anion currents. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:4405–16.</span> [<a href="/pubmed/23793458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23793458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.choi.2017.516">Choi SA, Kim SY, Yoon J, Choi J, Park SS, Seong MW, Kim H, Hwang H, Choi JE, Chae JH, Kim KJ, Kim S, Lee YJ, Nam SO, Lim BC. A unique mutational spectrum of MLC1 in Korean patients with megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">Ann Lab Med. </span>2017;<span class="ref-vol">37</span>:516–21.</span> [<a href="/pmc/articles/PMC5587825/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5587825</span></a>] [<a href="/pubmed/28840990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28840990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.chung_moh.2005.833">Chung Moh M, Hoon Lee L, Shen S. Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma. <span><span class="ref-journal">J Hepatol. </span>2005;<span class="ref-vol">42</span>:833–41.</span> [<a href="/pubmed/15885354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15885354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.devaney.2002.419">Devaney JM, Donarum EA, Brown KM, Meyer J, St&#x000f6;ber G, Lesch KP, Nestadt G, Stephan DA, Pulver AE. No missense mutation of WKL1 in a subgroup of probands with schizophrenia. <span><span class="ref-journal">Mol Psychiatry. </span>2002;<span class="ref-vol">7</span>:419–23.</span> [<a href="/pubmed/11986987" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11986987</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.duarri.2011.228">Duarri A, Lopez de Heredia M, Capdevila-Nortes X, Ridder MC, Montolio M, L&#x000f3;pez-Hern&#x000e1;ndez T, Boor I, Lien CF, Hagemann T, Messing A, Gorecki DC, Scheper GC, Mart&#x000ed;nez A, Nunes V, van der Knaap MS, Est&#x000e9;vez R. Knockdown of MLC1 in primary astrocytes causes cell vacuolation: A MLC disease cell model. <span><span class="ref-journal">Neurobiol Dis. </span>2011;<span class="ref-vol">43</span>:228–38.</span> [<a href="/pmc/articles/PMC3885813/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3885813</span></a>] [<a href="/pubmed/21440627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21440627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.dubey.2018.636">Dubey M, Brouwers E, Hamilton EMC, Stiedl O, Bugiani M, Koch H, Kole MHP, Boschert U, Wykes RC, Mansvelder HD, van der Knaap MS, Min R. Seizures and disturbed brain potassium dynamics in the leukodystrophy megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">Ann Neurol. </span>2018;<span class="ref-vol">83</span>:636–49.</span> [<a href="/pmc/articles/PMC5900999/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5900999</span></a>] [<a href="/pubmed/29466841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29466841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.dubey.2015.114">Dubey M, Bugiani M, Ridder MC, Postma NL, Brouwers E, Polder E, Jacobs JG, Baayen JC, Klooster J, Kamermans M, Aardse R, de Kock CP, Dekker MP, van Weering JR, Heine VM, Abbink TE, Scheper GC, Boor I, Lodder JC, Mansvelder HD, van der Knaap MS. Mice with megalencephalic leukoencephalopathy with cysts: a developmental angle. <span><span class="ref-journal">Ann Neurol. </span>2015;<span class="ref-vol">77</span>:114–31.</span> [<a href="/pubmed/25382142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25382142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.favrekontula.2008.633">Favre-Kontula L, Rolland A, Bernasconi L, Karmirantzou M, Power C, Antonsson B, Boschert U. GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system. <span><span class="ref-journal">Glia. </span>2008;<span class="ref-vol">56</span>:633–45.</span> [<a href="/pubmed/18293412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18293412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.gorospe.2004.878">Gorospe JR, Singhal BS, Kainu T, Wu F, Stephan D, Trent J, Hoffman EP, Naidu S. Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:878–82.</span> [<a href="/pubmed/15037685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15037685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.hoeggbeiler.2014.3475">Hoegg-Beiler MB, Sirisi S, Orozco IJ, Ferrer I, Hohensee S, Auberson M, G&#x000f6;dde K, Vilches C, de Heredia ML, Nunes V, Est&#x000e9;vez R, Jentsch TJ. Disrupting MLC1 and GlialCAM and ClC-2 interactions in leukodystrophy entails glial chloride channel dysfunction. <span><span class="ref-journal">Nat Commun. </span>2014;<span class="ref-vol">5</span>:3475.</span> [<a href="/pubmed/24647135" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24647135</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.ilja_boor.2006.505">Ilja Boor PK, de Groot K, Mejaski-Bosnjak V, Brenner C, van der Knaap MS, Scheper GC, Pronk JC. Megalencephalic leukoencephalopathy with subcortical cysts: an update and extended mutation analysis of MLC1. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:505–12.</span> [<a href="/pubmed/16652334" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16652334</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.itoh.2006.243">Itoh N, Maeda M, Naito Y, Narita Y, Kuzuhara S. An adult case of megalencephalic leukoencephalopathy with subcortical cysts with S93L mutation in MLC1 gene: a case report and diffusion MRI. <span><span class="ref-journal">Eur Neurol. </span>2006;<span class="ref-vol">56</span>:243–5.</span> [<a href="/pubmed/17077634" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17077634</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.jeworutzki.2012.951">Jeworutzki E, L&#x000f3;pez-Hern&#x000e1;ndez T, Capdevila-Nortes X, Sirisi S, Bengtsson L, Montolio M, Zifarelli G, Arnedo T, M&#x000fc;ller CS, Schulte U, Nunes V, Mart&#x000ed;nez A, Jentsch TJ, Gasull X, Pusch M, Est&#x000e9;vez R. GlialCAM, a protein defective in a leukodystrophy, serves as a ClC-2 Cl(-) channel auxiliary subunit. <span><span class="ref-journal">Neuron. </span>2012;<span class="ref-vol">73</span>:951–61.</span> [<a href="/pmc/articles/PMC3334819/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3334819</span></a>] [<a href="/pubmed/22405205" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22405205</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.kaganovich.2004.31">Kaganovich M, Peretz A, Ritsner M, Bening Abu-Shach U, Attali B, Navon R. Is the WKL1 gene associated with schizophrenia? <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2004;<span class="ref-vol">125B</span>:31–7.</span> [<a href="/pubmed/14755440" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14755440</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.kariminejad.2015.71">Kariminejad A, Rajaee A, Ashrafi MR, Alizadeh H, Tonekaboni SH, Malamiri RA, Ghofrani M, Karimzadeh P, Mohammadi MM, Baghalshooshtari A, Bozorgmehr B, Kariminejad MH, Postma N, Abbink TE, van der Knaap MS. Eight novel mutations in MLC1 from 18 Iranian patients with megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">Eur J Med Genet. </span>2015;<span class="ref-vol">58</span>:71–4.</span> [<a href="/pubmed/25497041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25497041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.leegwater.2002.279">Leegwater PA, Boor PK, Yuan BQ, van der Steen J, Visser A, Konst AA, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS. Identification of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">Hum Genet. </span>2002;<span class="ref-vol">110</span>:279–83.</span> [<a href="/pubmed/11935341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11935341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.leegwater.2001.831">Leegwater PA, Yuan BQ, van der Steen J, Mulders J, Konst AA, Boor PK, Mejaski-Bosnjak V, van der Maarel SM, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS. Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:831–8.</span> [<a href="/pmc/articles/PMC1275636/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1275636</span></a>] [<a href="/pubmed/11254442" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11254442</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez T, Ridder MC, Montolio M, Capdevila-Nortes X, Polder E, Sirisi S, Duarri A, Schulte U, Fakler B, Nunes V, Scheper GC, Mart&#x000ed;nez A, Est&#x000e9;vez R, van der Knaap MS. Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">88</span>:422–32.</span> [<a href="/pmc/articles/PMC3071909/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3071909</span></a>] [<a href="/pubmed/21419380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21419380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.meyer.2001.302">Meyer J, Huberth A, Ortega G, Syagailo YV, Jatzke S, Mossner R, Strom TM, Ulzheimer-Teuber I, Stober G, Schmitt A, Lesch KP. A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. <span><span class="ref-journal">Mol Psychiatry. </span>2001;<span class="ref-vol">6</span>:302–6.</span> [<a href="/pubmed/11326298" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11326298</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.montagna.2006.292">Montagna G, Teijido O, Eymard-Pierre E, Muraki K, Cohen B, Loizzo A, Grosso P, Tedeschi G, Palac&#x000ed;n M, Boespflug-Tanguy O, Bertini E, Santorelli FM, Est&#x000e9;vez R. Vacuolating megalencephalic leukoencephalopathy with subcortical cysts: functional studies of novel variants in MLC1. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:292.</span> [<a href="/pubmed/16470554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16470554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.ridder.2011.3342">Ridder MC, Boor I, Lodder JC, Postma NL, Capdevila-Nortes X, Duarri A, Brussaard AB, Est&#x000e9;vez R, Scheper GC, Mansvelder HD, van der Knaap MS. Megalencephalic leucoencephalopathy with cysts: defect in chloride currents and cell volume regulation. <span><span class="ref-journal">Brain. </span>2011;<span class="ref-vol">134</span>:3342–54.</span> [<a href="/pubmed/22006981" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22006981</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.rubie.2003.45">Rubie C, Lichtner P, Gartner J, Siekiera M, Uziel G, Kohlmann B, Kohlschutter A, Meitinger T, Stober G, Bettecken T. Sequence diversity of KIAA0027/MLC1: are megalencephalic leukoencephalopathy and schizophrenia allelic disorders? <span><span class="ref-journal">Hum Mutat. </span>2003;<span class="ref-vol">21</span>:45–52.</span> [<a href="/pubmed/12497630" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12497630</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.selch.2007.1211">Selch S, Strobel A, Haderlein J, Meyer J, Jacob CP, Schmitt A, Lesch KP, Reif A. MLC1 polymorphisms are specifically associated with periodic catatonia, a subgroup of chronic schizophrenia. <span><span class="ref-journal">Biol Psychiatry. </span>2007;<span class="ref-vol">61</span>:1211–4.</span> [<a href="/pubmed/17210142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17210142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.shimada.2014.14019">Shimada S, Shimojima K, Masuda T, Nakayama Y, Kohji T, Tsukamoto H, Matsubasa T, Oka A, Yamamoto T. MLC1 mutations in Japanese patients with megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">Hum Genome Var. </span>2014;<span class="ref-vol">1</span>:14019.</span> [<a href="/pmc/articles/PMC4785519/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4785519</span></a>] [<a href="/pubmed/27081509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27081509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.singhal.2003.646">Singhal BS, Gorospe JR, Naidu S. Megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">J Child Neurol. </span>2003;<span class="ref-vol">18</span>:646–52.</span> [<a href="/pubmed/14572144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14572144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.spijker.2010.179">Spijker S, Van Zanten JS, De Jong S, Penninx BW, van Dyck R, Zitman FG, Smit JH, Ylstra B, Smit AB, Hoogendijk WJ. Stimulated gene expression profiles as a blood marker of major depressive disorder. <span><span class="ref-journal">Biol Psychiatry. </span>2010;<span class="ref-vol">68</span>:179–86.</span> [<a href="/pubmed/20471630" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20471630</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.sugiura.2006.286">Sugiura C, Shiota M, Maegaki Y, Yoshida K, Koeda T, Kitahara T, Ohno K. Late-onset neuropsychological symptoms in a Japanese patient with megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">Neuropediatrics. </span>2006;<span class="ref-vol">37</span>:286–90.</span> [<a href="/pubmed/17236107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17236107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.teijido.2004.2581">Teijido O, Mart&#x000ed;nez A, Pusch M, Zorzano A, Soriano E, Del R&#x000ed;o JA, Palac&#x000ed;n M, Est&#x000e9;vez R. Localization and functional analyses of the MLC1 protein involved in megalencephalic leukoencephalopathy with subcortical cysts. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:2581–94.</span> [<a href="/pubmed/15367490" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15367490</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.top_u.1998.142">Top&#x000e7;u M, Saatci I, Topcuoglu MA, Kose G, Kunak B. Megalencephaly and leukodystrophy with mild clinical course: a report on 12 new cases. <span><span class="ref-journal">Brain Dev. </span>1998;<span class="ref-vol">20</span>:142–53.</span> [<a href="/pubmed/9628190" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9628190</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.van_der_knaap.1996.206">van der Knaap MS, Barth PG, Vrensen GF, Valk J. Histopathology of an infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course. <span><span class="ref-journal">Acta Neuropathol (Berl). </span>1996;<span class="ref-vol">92</span>:206–12.</span> [<a href="/pubmed/8841668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8841668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.van_der_knaap.2012.973">van der Knaap MS, Boor I, Est&#x000e9;vez R. Megalencephalic leukoencephalopathy with subcortical cysts: chronic white matter oedema due to a defect in brain ion and water homoeostasis. <span><span class="ref-journal">Lancet Neurol. </span>2012;<span class="ref-vol">11</span>:973–85.</span> [<a href="/pubmed/23079554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23079554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.van_der_voorn.2006.510">van der Voorn JP, Pouwels PJW, Hart AA, Serrarens J, Willemsen MA, Kremer HP, Barkhof F, van der Knaap MS. Childhood white matter disorders: quantitative MR imaging and spectroscopy. <span><span class="ref-journal">Radiology. </span>2006;<span class="ref-vol">241</span>:510–7.</span> [<a href="/pubmed/17057071" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17057071</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.verma.2005.16">Verma R, Mukerji M, Grover D. B-Rao C, Das SK, Kubendran S, Jain S, Brahmachari SK. MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India. <span><span class="ref-journal">Biol Psychiatry. </span>2005;<span class="ref-vol">58</span>:16–22.</span> [<a href="/pubmed/15992519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15992519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mlc.REF.wu.2016.36218">Wu M, Moh MC, Schwarz H. HepaCAM associates with connexin 43 and enhances its localization in cellular junctions. <span><span class="ref-journal">Sci Rep. </span>2016;<span class="ref-vol">6</span>:36218.</span> [<a href="/pmc/articles/PMC5098153/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5098153</span></a>] [<a href="/pubmed/27819278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27819278</span></a>]</div></li></ul></div></div><div id="mlc.Chapter_Notes"><h2 id="_mlc_Chapter_Notes_">Chapter Notes</h2><div id="mlc.Author_History"><h3>Author History</h3><p>Truus EM Abbink, PhD (2018-present)<br />Rogier Min, PhD (2018-present)<br />JC Pronk, PhD; Vrije Universiteit Medical Center, Amsterdam (2003-2008)<br />Gert C Scheper, PhD; Vrije Universiteit Medical Center, Amsterdam (2008-2018)<br />Marjo S van der Knaap, MD, PhD (2003-present)</p></div><div id="mlc.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 March 2018 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 November 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 July 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 November 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 August 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>12 June 2003 (mvdk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1535</span><span class="label">PMID: <a href="/pubmed/20301707" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301707</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mmihs-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/miccap-ms/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1535&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1535/?report=reader">PubReader</a></li><li><a href="/books/NBK1535/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1535" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1535" style="display:none" title="Cite this Page"><div class="bk_tt">van der Knaap MS, Abbink TEM, Min R. Megalencephalic Leukoencephalopathy with Subcortical Cysts. 2003 Aug 11 [Updated 2018 Mar 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1535/pdf/Bookshelf_NBK1535.pdf">PDF version of this page</a> (566K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mlc.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mlc.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#mlc.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#mlc.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#mlc.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#mlc.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#mlc.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#mlc.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mlc.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#mlc.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mlc.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=220296[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HEPACAM</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23209[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MLC1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1535+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1483496" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1483496" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1483496" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1483496" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20437615" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">HTRA1</i> Disorder</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">HTRA1</i> Disorder<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Onodera O, Nozaki H, Fukutake T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21419380" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism.</a><span class="source">[Am J Hum Genet. 2011]</span><div class="brieflinkpop offscreen_noflow">Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">López-Hernández T, Ridder MC, Montolio M, Capdevila-Nortes X, Polder E, Sirisi S, Duarri A, Schulte U, Fakler B, Nunes V, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2011 Apr 8; 88(4):422-32. Epub 2011 Mar 17.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301601" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mole SE, Williams RE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24315536" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical, neuroimaging, and genetic characteristics of megalencephalic leukoencephalopathy with subcortical cysts in Egyptian patients.</a><span class="source">[Pediatr Neurol. 2014]</span><div class="brieflinkpop offscreen_noflow">Clinical, neuroimaging, and genetic characteristics of megalencephalic leukoencephalopathy with subcortical cysts in Egyptian patients.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mahmoud IG, Mahmoud M, Refaat M, Girgis M, Waked N, El Badawy A, Selim L, Hassan S, Abdel Aleem AK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Neurol. 2014 Feb; 50(2):140-8. Epub 2013 Oct 24.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301707" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301707" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04291edd21425a259a4b5b">Megalencephalic Leukoencephalopathy with Subcortical Cysts - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Megalencephalic Leukoencephalopathy with Subcortical Cysts - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:29:34-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B934CE04288710000000000410012&amp;ncbi_session=CE8B934CE04291D1_0065SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1535%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1535&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1535/&amp;ncbi_pagename=Megalencephalic Leukoencephalopathy with Subcortical Cysts - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B934CE04291D1_0065SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>